TrialCancer medicine2013
Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma.
Emil Lou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this paperpooled ittrialcites it